Literature DB >> 28965468

Misleading Guidance From Pharmacogenomic Testing.

Tahir Rahman1, David M Ash1, John Lauriello1, Roshni Rawlani1.   

Abstract

Keywords:  Antipsychotics; Genetics; Other Aspects Of Psychopharmacology; Pharmacogenetic Testing; Schizophrenia

Mesh：

Substances：

Year:  2017        PMID： 28965468     DOI： 10.1176/appi.ajp.2017.16121353

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  3 in total

1.  Pharmacogenomics at the Point of Care: A Community Pharmacy Project in British Columbia.

Authors:  Samantha Breaux; Francis Arthur Derek Desrosiers; Mauricio Neira; Sunita Sinha; Corey Nislow
Journal:  J Pers Med       Date:  2020-12-24

2.  Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future.

Authors:  Chiara Fabbri; Alessandro Serretti
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

Review 3.  Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?

Authors:  Roos van Westrhenen; Katherine J Aitchison; Magnus Ingelman-Sundberg; Marin M Jukić
Journal:  Front Psychiatry       Date:  2020-03-12       Impact factor: 4.157
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.